Skip to content

Insider · CIK 0001766522

Bryan Ball

officer

Files at WHWK (Whitehawk Therapeutics, Inc.). First filing Mar 4, 2025, latest Mar 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $5,045 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
WHWKsell 3
Whitehawk Therapeutics, Inc.
$5,045
2,147 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+91,633$0.00$091,63324 d ago
Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+91,633$0.00$091,63324 d ago
Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+91,633$0.00$091,63327 d ago
Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+91,633$0.00$091,63327 d ago
Apr 1, 2025WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+366,532$0.00$0366,532Apr 3, 2025
Apr 1, 2025WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+366,532$0.00$0366,532Apr 3, 2025
Mar 1, 2025WHWK
Whitehawk Therapeutics, Inc.
MOption exercise
Common Stock
+5,000--105,000Mar 4, 2025
Mar 3, 2025WHWK
Whitehawk Therapeutics, Inc.
SOpen-market sale
Common Stock
-2,147$2.35$5,045102,853Mar 4, 2025
Mar 4, 2025WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Common Stock
+100,000$2.40$240k202,853Mar 4, 2025
Mar 1, 2025WHWK
Whitehawk Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-5,000$0.00$015,000Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bryan Ball: insider trades and track record | InsiderTell